EmilySlotkinMD

Pediatric Hematology & Oncology • New York, NY

Pediatric Sarcoma Oncology

Physician

Request Appointment

Overview of Dr. Slotkin

Dr. Emily Slotkin is a pediatric hematologist/oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from University at Buffalo School of Medicine and has been in practice 12 years. She is one of 96 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pediatric Hematology & Oncology. She has more than 30 publications and over 500 citings.

Office
1275 York Avenue
New York, NY 10065
Book by Phone+1(231) 674-8995

Education & Training

Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2008 - 2011
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2008
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2011 - 2026
NJ State Medical License 2024 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma
Available
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor Start of enrollment: 2020 Dec 22
Recruiting
A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor Start of enrollment: 2022 Mar 02
Recruiting
Phase 2
Roles: Contact, Principal Investigator
A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum Start of enrollment: 2019 Jul 15
Recruiting
Phase 2
Roles: Principal Investigator, Contact
A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors Start of enrollment: 2020 Dec 10
Terminated
Phase 2
Roles: Contact
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 Start of enrollment: 2022 Nov 17
Recruiting
Phase 1
Roles: Contact
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer Start of enrollment: 2021 Aug 09
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement.
Matthew S Dietz, Alyaa Al-Ibraheemi, Jessica L Davis, C Matthew Hawkins, Brian T Craig
Journal of the National Comprehensive Cancer Network. 2024-12-27
Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials.
Damon R Reed, Asmin Tulpule, Jonathan Metts, Matteo Trucco, Mark Robertson-Tessi
Journal of Clinical Oncology. 2024-09-01
Harmonization of the Upfront Osteosarcoma Treatment Paradigm for Adolescents and Young Adults.
Nicole P Daukshus, Viswatej Avutu, Emily Long Sarro, Michael D Kinnaman, Emily K Slotkin
Journal of Adolescent and Young Adult Oncology. 2024-07-15

Press Mentions

Drug Combination Shows Promise for Rhabdomyosarcoma, but Can It Get to Clinical Trials?December 9th, 2022